Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 3661-3680 of 3,895 trials

Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

NCT00337493

This study will determine which, if any, allelic variants of mycophenolic acid (MPA) metabolizing enzymes, drug transporters and drug targets are associated with the observed variation in pharmacokinetic and pharmacodynamic outcomes observed with CellCept usage. Patients participating in study ML17225 will be eligible for this pharmacogenetic investigation, and will have one additional blood sample taken during the study. The anticipated time on study treatment in study ML17225 is 1-2 years, and the target sample size is 500+ individuals.

Kidney Transplantation

Hoffmann-La Roche155 participantsStarted Dec 2005

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +17 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection

NCT00300274

This trial was to examine the impact of everolimus and reduced dose of cyclosporine on efficacy and safety compared to mycophenolate mofetil and a standard dose of cyclosporine in heart transplant recipients.

Graft Rejection

Novartis Pharmaceuticals721 participantsStarted Jan 2006

Los Angeles, California, United States • San Francisco, California, United States • Stanford, California, United States +61 more locations

Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection

Rheumatoid Arthritis Trials in Other Cities

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines

Beat the Blues: Treating Depression in African American Elders

Tesetaxel for Previously Treated Patients With Bladder Cancer

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)

A Clinical Study of the Dynesys(R) Spinal System

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

Ultrasound Visualization Versus Electrical Nerve Stimulation

CIS001 Extension Study of Cyclosporine Inhalation Solution

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Calfactant for Direct Acute Respiratory Distress Syndrome

Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.

A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

Other Conditions in Philadelphia